Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Nuffield Trust and The King’s Fund seek views on proposed ‘Future of community pharmacy’ vision

Nuffield Trust and The King’s Fund are seeking feedback from community pharmacy on their proposals for the future of community pharmacy and they are seeking feedback from community pharmacy stakeholders.

The online survey is the latest opportunity for pharmacy owners, LPCs and others in the sector to engage with the project to develop a Vision for Community Pharmacy.


Nuffield Trust and The King’s Fund want to hear their views on their proposals, ahead of the publication of the final report later this year. The vision is critically important, as it will be used to develop the future strategy for the sector and lay the groundwork for the next Community Pharmacy Contractual Framework (CPCF) negotiations.

The survey is asking for thoughts on key aspects of the vision and its recommendations. The vision has been developed by Nuffield Trust and The King’s Fund following an extensive programme of research, interviews and meetings of the vision Steering Group, Advisory Panel, and Working Groups, all of which have contractors, LPCs and other representatives of the sector at their heart.

The vision project team are looking forward to hearing views from across the sector on their proposals and what will need to happen to make them a reality.

The deadline for responses is 11.59pm on Monday (14 August).

In addition to the survey, the Community Pharmacy England is hosting an online engagement event with Nuffield Trust and The King’s Fund on Tuesday (25 July) at 7pm. This will allow any pharmacy owners to hear more from the authors of the report and to discuss their proposals.

This important project was commissioned by Community Pharmacy England to work towards a better future, laying the ground for the next Community Pharmacy Contractual Framework (CPCF) negotiations which will be critical for the future of all community pharmacies.

Commenting on the launch of the latest vision engagement exercise, Community Pharmacy England Chief Executive Janet Morrison said: “As community pharmacy owners and their teams work tirelessly in the face of a relentless workload and financial pressures, a chink of light in the shape of a £645m investment in service development has appeared. We need to build on that momentum as we edge ever closer to the end of the five-year CPCF.

“Having commissioned Nuffield Trust and The King’s Fund to develop a Vision for Community Pharmacy last year, we are eager to see what the sector makes of their proposals and implementation ideas. We need pharmacy owners and LPCs to check the recommendations and tell the project team what works and, more importantly, what doesn’t.

“This vision is critical for the future direction of the sector, so it’s apt that we are launching this final call for feedback at such an important time for healthcare. What we need now is views from the full breadth of community pharmacy so Nuffield Trust and The King’s Fund can finalise their recommendations, and we can take this forward with the backing of the whole sector. Only you can help make that vision a reality.”

More For You

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

iStock

Locums should stand up for their interests, say 'no' to unfair terms: PDA

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to be vigilant about their interests and negotiate directly with their businesses, avoid working with digital platforms driven by algorithms, and be aware of regressive contract terms.

The not-for-profit organisation issued such an advisory following its survey of 1,300 UK locum pharmacists, which showed that they work in a difficult environment and that most are dissatisfied with their jobs.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less